NCT06966323 Hold me Tight/Let me Go: Effectiveness of a Course to Enhance Parent-adolescent Relationship
| NCT ID | NCT06966323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Amsterdam |
| Condition | Parent Training |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-06-11 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-06-11 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
HmT/LmG is a group course for 4-6 parental dyads and consists of 4 group sessions with psycho-education and skills training and 3 individual sessions per family (i.e., 1 session with the adolescent, 1 session with the parents, and 1 session with parents and adolescent together). We want to evaluate effectiveness and treatment process mechanisms applying self-reports, audio observation and interviews.
Eligibility Criteria
We will include: 1. Families with one or both parents/primary caretaker (single parent or blended families are allowed) with one adolescent of 12 to 18 years of age; 2. Adolescent problems are deemed to be exacerbated by a stressful parent-adolescent relationship. We will exclude: 1. Participants in command of the Dutch language. 2. Parents/primary caretakers and adolescents with severe psychopathology (e.g., psychosis, acute suicidality, severe depression) that will interfere with participation in the program. 3. Parents/primary caretakers already attending systemic therapy or intensive parental guidance during the waiting period and during HmT/LmG. Other individual therapy will be registered during intake, and afterwards by the therapists. During follow-up systemic interventions are allowed but have to be registered.
Contact & Investigator
Henk Jan Conradi, Doctor of Philosophy
PRINCIPAL INVESTIGATOR
University of Amsterdam
Frequently Asked Questions
Who can join the NCT06966323 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Parent Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06966323 currently recruiting?
Yes, NCT06966323 is actively recruiting participants. Contact the research team at s.jonker@uva.nl for enrollment information.
Where is the NCT06966323 trial being conducted?
This trial is being conducted at Almere Stad, Netherlands, Almere Stad, Netherlands, Bilthoven, Netherlands, Hilversum, Netherlands and 1 additional location.
Who is sponsoring the NCT06966323 clinical trial?
NCT06966323 is sponsored by University of Amsterdam. The principal investigator is Henk Jan Conradi, Doctor of Philosophy at University of Amsterdam. The trial plans to enroll 150 participants.